Search

Amy Jo Sterling

Examiner (ID: 4242, Phone: (571)272-6823 , Office: P/3631 )

Most Active Art Unit
3631
Art Unit(s)
3632, 3631
Total Applications
2801
Issued Applications
2050
Pending Applications
118
Abandoned Applications
672
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 82198 [patent_doc_number] => 07745579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-29 [patent_title] => 'Inhibitor of NF-KB activation' [patent_app_type] => utility [patent_app_number] => 09/671687 [patent_app_country] => US [patent_app_date] => 2000-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23431 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745579.pdf [firstpage_image] =>[orig_patent_app_number] => 09671687 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/671687 		Inhibitor of NF-KB activation Sep 27, 2000 Issued
Array ( [id] => 1309936 [patent_doc_number] => 06610302 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I' [patent_app_type] => B1 [patent_app_number] => 09/669642 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 5943 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610302.pdf [firstpage_image] =>[orig_patent_app_number] => 09669642 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/669642 		Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I Sep 25, 2000 Issued
09/665728 Secreted factors Sep 19, 2000 Abandoned
Array ( [id] => 1357454 [patent_doc_number] => 06573068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Claudin-50 protein' [patent_app_type] => B1 [patent_app_number] => 09/663600 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 135186 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573068.pdf [firstpage_image] =>[orig_patent_app_number] => 09663600 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/663600 		Claudin-50 protein Sep 14, 2000 Issued
Array ( [id] => 1220372 [patent_doc_number] => 06703221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-09 [patent_title] => 'Notch receptor ligands and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/641612 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20830 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703221.pdf [firstpage_image] =>[orig_patent_app_number] => 09641612 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/641612 		Notch receptor ligands and uses thereof Aug 16, 2000 Issued
Array ( [id] => 1574351 [patent_doc_number] => 06468756 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Methods of identifying compounds that bind to SNORF25 receptors' [patent_app_type] => B1 [patent_app_number] => 09/641259 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 39670 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468756.pdf [firstpage_image] =>[orig_patent_app_number] => 09641259 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/641259 		Methods of identifying compounds that bind to SNORF25 receptors Aug 16, 2000 Issued
09/637856 Human tumor necrosis factor receptor TR16 Aug 9, 2000 Abandoned
Array ( [id] => 1326375 [patent_doc_number] => 06599716 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Nucleic acids encoding NTR3, a member of the TNF-receptor supergene family' [patent_app_type] => B1 [patent_app_number] => 09/632277 [patent_app_country] => US [patent_app_date] => 2000-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 43328 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599716.pdf [firstpage_image] =>[orig_patent_app_number] => 09632277 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/632277 		Nucleic acids encoding NTR3, a member of the TNF-receptor supergene family Aug 2, 2000 Issued
09/627081 SECRETED PROTEIN HCE3F11 Jul 26, 2000 Abandoned
09/618570 Human tumor necrosis factor receptors TR13 and TR14 Jul 13, 2000 Abandoned
09/611989 Isolation, identification and characterization of YMKZ5, a novel member of the TNF-receptor supergene family Jul 6, 2000 Abandoned
Array ( [id] => 1295475 [patent_doc_number] => 06627199 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family' [patent_app_type] => B1 [patent_app_number] => 09/612033 [patent_app_country] => US [patent_app_date] => 2000-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49621 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627199.pdf [firstpage_image] =>[orig_patent_app_number] => 09612033 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/612033 		Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family Jul 6, 2000 Issued
09/610635 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof Jul 4, 2000 Abandoned
09/608921 METHODS FOR IDENTIFYING COMPOUNDS SUITABLE FOR THE TREATMENT OF CELLULAR PROLIFERATION, GROWTH, DIFFERENTIATION, OR MIGRATION DISORDERS Jun 29, 2000 Abandoned
Array ( [id] => 740606 [patent_doc_number] => 07029857 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Processes for obtaining compounds employing SNORF72 receptors' [patent_app_type] => utility [patent_app_number] => 09/609146 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 33905 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/029/07029857.pdf [firstpage_image] =>[orig_patent_app_number] => 09609146 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/609146 		Processes for obtaining compounds employing SNORF72 receptors Jun 29, 2000 Issued
09/606317 Membrane-associated and secreted proteins and uses thereof Jun 28, 2000 Abandoned
09/605682 USES OF THE HL-18A RECEPTOR Jun 25, 2000 Abandoned
09/602871 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses Jun 22, 2000 Abandoned
09/597993 Secreted proteins and uses thereof Jun 18, 2000 Abandoned
Array ( [id] => 1100885 [patent_doc_number] => 06814966 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-09 [patent_title] => 'Methods for treating glaucoma' [patent_app_type] => B1 [patent_app_number] => 09/591561 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19030 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/814/06814966.pdf [firstpage_image] =>[orig_patent_app_number] => 09591561 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/591561 		Methods for treating glaucoma Jun 12, 2000 Issued
Menu